Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization
NCT03142412 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2500
Last updated 2018-06-28
Summary
To develop a test to characterize and monitor SLE disease activity status from a participant's home by analyzing the gene expression from participant self-collected blood samples using a novel fingerstick collection kit.
Conditions
- Systemic Lupus Erythematosus
- Lupus
- Lupus Erythematosus
- Lupus Erythematosus, Systemic
Sponsors & Collaborators
-
DxTerity Diagnostics
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-04-17
- Primary Completion
- 2021-10-17
- Completion
- 2021-10-17
Countries
- United States
Study Locations
More Related Trials
-
Accuracy, Feasibility and Acceptance of CGM Lupus
NCT03296995 ·Status: UNKNOWN ·Phase: NA
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
Establishing Clinical Utility of a New Diagnostic Test for Rheumatology Patients
NCT04266860 ·Status: COMPLETED ·Phase: NA
-
Development of a Dietary Intervention Model Based on Genetic Data as an Implementation of a Healthy Lifestyle in the Management of Systemic Lupus Erythematosus Patients
NCT07183007 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study of Systemic Lupus Erythematosus
NCT00001372 ·Status: RECRUITING
-
Atacicept Demonstrating Dose RESponSe
NCT01440231 ·Status: WITHDRAWN ·Phase: PHASE2
-
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
NCT01405196 ·Status: COMPLETED ·Phase: PHASE2
-
Improving the Assessment of SLE Disease Activity
NCT03144063 ·Status: COMPLETED
-
Regulatory BCells in Systemic Lupus Erythematosus
NCT03178721 ·Status: UNKNOWN
-
Dynamic Imaging of Variation in Lupus Nephritis
NCT03180021 ·Status: COMPLETED
-
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
NCT02034344 ·Status: COMPLETED
-
PRediction Of Flares In Lupus With autoantibodiEs and Chemokines
NCT04951427 ·Status: UNKNOWN
-
Assessment of Blood Indices in Systemic Lupus Erythematosus
NCT06872086 ·Status: NOT_YET_RECRUITING
-
Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region
NCT03138941 ·Status: RECRUITING
-
A Pilot Study to Explore the Role of Gut Flora in Lupus
NCT04213690 ·Status: WITHDRAWN
-
Utilizing Qualitative and Quantitative Methods to Understand a New Model of Type 1 and 2 Systemic Lupus Erythematosus (SLE)
NCT05426902 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
NCT02446912 ·Status: COMPLETED ·Phase: PHASE3
-
Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)
NCT01781611 ·Status: TERMINATED ·Phase: NA
-
A Safety and Tolerability Study of MEDI-570 in Systemic Lupus Erythematosus
NCT01127321 ·Status: TERMINATED ·Phase: PHASE1
-
miR-101-3p and Autotaxin in SLE Patients
NCT07252141 ·Status: NOT_YET_RECRUITING
-
A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus
NCT02725515 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Study Investigating Demographic and Clinical Characteristics of SLE Patients in Egypt
NCT07144514 ·Status: NOT_YET_RECRUITING
-
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
NCT07175285 ·Status: RECRUITING
-
Motivating Individuals With Lupus to Exercise
NCT05287581 ·Status: COMPLETED ·Phase: NA
-
Cardiac and Laboratory Findings in Patients With Systemic Lupus Erythematosus
NCT03179046 ·Status: COMPLETED